HEIDELBERG
Germany
20
2015-08-13
14
2016-04-19
These are the the leading inventors for applications assigned to APOGENIX GMBH:
APOGENIX GMBH based in HEIDELBERG, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Composition comprising a mixture of CD95-Fc isoforms and methods of producing same
#2 | 2015-06-18 ✅ Patent 9,434,783 granted on 2016-09-06Shortened CD95-Fc variant fusion proteins, nucleic acids and host cells thereof
#3 | 2015-06-18 ✅ Patent 9,540,431 granted on 2017-01-10Inhibitors of the CD95 signaling pathway for treatment of MDS
#4 | 2015-05-07 ✅ Patent 9,212,211 granted on 2015-12-15Trail collectin fusion proteins
#5 | 2014-06-19 ✅ Patent 9,469,681 granted on 2016-10-18Fusion proteins forming trimers
#6 | 2014-02-27 ✅ Patent 8,921,519 granted on 2014-12-30Single chain fusion polypeptides comprising soluble light cytokine domains
#7 | 2013-07-11 ✅ Patent 8,907,063 granted on 2014-12-09TNF superfamily collectin fusion proteins and encoding nucleic acids
#8 | 2012-06-14 ✅ Patent 8,580,273 granted on 2013-11-12TNF superfamily member light fusion proteins
#9 | 2012-02-16 ✅ Patent 8,664,366 granted on 2014-03-04Fusion proteins forming trimers
#10 | 2011-07-14METHODS AND COMPOSITIONS FOR PREVENTING RADIATION-INDUCED PNEUMONITIS
#11 | 2011-06-30 ✅ Patent 8,450,460 granted on 2013-05-28Single-chain TNFSF fusion polypeptides
#12 | 2011-05-12 ✅ Patent 8,592,557 granted on 2013-11-26Multimeric TNF receptor fusion proteins and nucleic acids encoding same
#13 | 2011-02-03 ✅ Patent 8,147,843 granted on 2012-04-03CD95L or trail fusion proteins
#14 | 2010-11-25ANTIBODY SPECIFIC FOR HUMAN IL-4 FOR THE TREATMENT OF CANCER
#15 | 2010-08-05 ✅ Patent 8,383,774 granted on 2013-02-26Collectin fusion proteins comprising TNF or trail
#16 | 2010-05-06IL-4 RECEPTOR AND IL-13 AS PROGNOSTIC MARKERS FOR COLON AND PANCREAS TUMORS
#17 | 2010-04-08HUMAN IL-4 MUTEINS IN CANCER THERAPY
#18 | 2009-08-06METHODS AND COMPOSITIONS FOR PREVENTING RADIATION-INDUCED PNEUMONITIS
#19 | 2007-12-20Method for the Purification and Amplification of Tumoral Stem Cells
#20 | 2007-11-22 ✅ Patent 8,007,813 granted on 2011-08-30CD95-Fc fusion proteins
Also check out Apogenix GmbH's (Heidelberg, Germany) applicant profile with 10 patent applications submitted.
30032 ⎘